dvm3602d
FDA notifies veterinarians of adverse events linked to osteoarthritis treatment
In a recent “Dear Veterinarian” letter, the FDA alerted veterinarians of adverse events in dogs treated with bedinvetmab ...
Zacks.com on MSN3d
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia
Solid Biosciences Inc. SLDB announced that the FDA has cleared its investigational new drug (IND) application to begin ...
Solid Biosciences's IND For Gene Therapy To Treat Friedreich's Ataxia Gets FDA Clearance
SGT-212 is the company's novel, AAV-based FA gene therapy candidate designed to deliver full-length frataxin via systemic intravenous (IV) infusion as well as direct intradentate nuclei (IDN) infusion ...